A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/407 (2006.01) A61K 31/553 (2006.01) A61P 7/00 (2006.01)
Patent
CA 2589202
The present invention relates to the use of staurosporines derivatives for the preparation of a drug for the treatment of diseases involving ras or FGFR3 signalling pathways and / or c-fos transcription, especially for the curative and/or prophylactic treatment of myeloma or multiple Myeloma, and to a method of treating diseases involving ras or FGFR3 signalling pathways and / or c-fos transcription.
L'invention concerne l'utilisation de dérivés de staurosporine pour préparer un médicament destiné à traiter des maladies impliquant des voies de signalisation Ras ou FGFR3 et/ou une transcription c-Fos, et permettant de traiter, en particulier, de manière curative et/ou prophylactique un myélome ou un myélome multiple. L'invention concerne également un procédé permettant de traiter des maladies impliquant des voies de signalisation Ras ou FGFR3 et/ou une transcription c-Fos.
Anderson C. Kenneth
Chen Jing
Gilliland D. Gary
Griffin James Douglas
Anderson C. Kenneth
Chen Jing
Dana-Farber Cancer Institute Inc.
Fetherstonhaugh & Co.
Gilliland D. Gary
LandOfFree
Use of staurosporine derivatives for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of staurosporine derivatives for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of staurosporine derivatives for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1825019